Amphastar Pharmaceuticals Inc logo

AMPH - Amphastar Pharmaceuticals Inc News Story

$18.68 0.6  3.5%

Last Trade - 07/05/21

Sector
Healthcare
Size
Mid Cap
Market Cap £638.0m
Enterprise Value £628.8m
Revenue £250.4m
Position in Universe 2962nd / 6858

BRIEF-Amphastar Pharmaceuticals Reports Financial Results For The Three Months And Full-Year Ended December 31, 2020

Mon 15th March, 2021 8:42pm
March 15 (Reuters) - Amphastar Pharmaceuticals Inc  AMPH.O :
    * AMPHASTAR PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR
THE
THREE MONTHS AND FULL-YEAR ENDED DECEMBER 31, 2020
    * Q4 GAAP LOSS PER SHARE $0.13
    * Q4 REVENUE $95.9 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$88.9
MILLION
    * Q4 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.16
    * Q4 EARNINGS PER SHARE ESTIMATE $0.14 -- REFINITIV IBES
DATA

Source text for Eikon:  ID:nGNXbn2tmN 
Further company coverage:  AMPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.